Champions of Care: The Lasting Impacts of the Pandemic on Healthcare

A complex healthcare system already full of challenges didn’t need a pandemic to come along and challenge it further, but it did.

Terry Zysk, CEO of LiveProcess, discussed those challenges and how the coordination of care in a hospital setting and management of various levels of staff, resources and supplies have changed since the start of the pandemic a year ago.

Zysk believes operation challenges in healthcare are not new results from the pandemic. They’ve existed for a long time, and all that COVID did was highlight those issues.

“I think there were quite a few unpredictable portions of the situation,” Zysk said. “And those came from treating an illness that we really didn’t understand.”

The duration of this peak demand for healthcare also left the United States’ healthcare system unprepared.

While the healthcare system did adapt to the pandemic, weaknesses in the way the U.S. structures healthcare became obvious.

“Proactive, structured approaches are more necessary now than ever before,” Zysk said. “While an individual organization might be capable of setting that up, it’s really something that needs to be done at the system level with each of the individual institutions and portions of the institution benefiting from a top-down and distributed model that can co-exist and operate together.”

Today, there are tools in place for individual healthcare systems to deal with COVID-19 and various situations caused by the pandemic. Still, the real issue, according to Zysk, is visibility from the enterprise side. Healthcare systems aren’t systemically communicating with one another, which reduces the ability to take advantage of resources, supplies, best practices and even beds to accommodate the shifts in demand.

“Instead of operating as a self-contained unit within a department or within the four walls of a hospital, healthcare systems need to operate more like a network of systems that can share their capacity, so you can effectively adapt and dynamically adjust to changes in demand,” Zysk said.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More